KEY MESSAGE FROM CHAIRPERSON & EXECUTIVE DIRECTOR
Dear Stakeholders,
On behalf of everyone at BAFNA PHARMACEUTICALS LIMITED, I would
like to begin by expressing my sincere gratitude for your continued support and
understanding regarding our business.
We look to grow consistently by increasing our market share of our
existing products portfolio. We always believe that progress and commercially viability in
this changing pharmaceutical business dynamics is only possible through hard work and
ethical practices.
Our sales revenues continue to grow strongly from INR 86.83 Crs in 2022
to INR 118.62 Crs in
2023 despite certain challenges. This success is because of our valued
customers and trustworthy partners who put their faith in us. At the same time we have an
internal driving force of dedicated and specialized team members who exceed the call of
duty realizing their true potential in our result driven and challenging work environment.
It is their efforts that make it possible for BAFNA to increase and grow our business
consistently.
We are well positioned for the future with our focused strategy and
ongoing investments in the facility, our manufacturing competence and advanced management
practices to achieve operational excellence. We will continue to make considerable
investments to strengthen our pipeline of affordable niche products.
We are very grateful to our Board of Directors for their continued guidance, advice and
support.
I once again thank our esteemed shareholders, partners and stakeholders for placing
their continued trust and confidence
in us.
Best Regards
Sd/-
S. Hemalatha
Chairperson & Executive Director
DIN:02714329